Log In
Print this Print this

Naloxone intranasal

  Manage Alerts
Collapse Summary General Information
Company Indivior plc
DescriptionNaloxone intranasal spray delivered by Aptar unitdose delivery device
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationAddiction
Indication DetailsTreat opioid overdose
Regulatory Designation U.S. - Fast Track (Treat opioid overdose)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today